Skip to content

Effect of CPAP on Breath Hold and Chest Movement in Normal Volunteers

Use of the Real-time Position Management (RPM) to Measure the Effects of Continuous Positive Airway Pressure (CPAP) on Duration of Breath Hold and Diaphragm Motion in Normal Volunteers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02545686
Acronym
CPAP_normal
Enrollment
10
Registered
2015-09-10
Start date
2015-09-30
Completion date
2019-09-30
Last updated
2017-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of CPAP on Chest Movement, Healthy Volunteers

Brief summary

CPAP will be applied to normal volunteers inorder to understand CPAP's effects on breathing and chest wall motion.

Detailed description

CPAP is a non-invasive ventilation technique that is commonly used to treat sleep apnea. Using a small air-pump, tubing and facemask, it provides a constant stream of pressurized air to the upper airways and lungs. Some of the physiological effects noted during CPAP are hyperinflation of the lungs, stabilizing and flattening of the diaphragm, and decrease in tidal volume. The effects on duration of breath hold are unknown. During radiation treatment, these effects are expected to reduce tumor and organ motion which reduces the volume of normal tissue being irradiated and also creates favorable treatment geometry by moving the heart away from the anterior chest wall. An important advantage of CPAP compared to other techniques is that active patient cooperation is not required. The potential exists to combine use of CPAP with other respiratory management techniques such as breath hold and improve overall effectiveness. When used in sleep apnea it is well tolerated and poses little risk to patients. There are no published reports of the use of CPAP in radiation therapy. In initial studies the Varian RPM system was used to assess respiratory motion with and without CPAP for patients receiving radiation therapy. This commercially available, non-invasive system works by directing an infrared beam onto an infrared motion detector that is placed on the patients' upper abdomen. The detector records the change in abdomen position that occurs with respiration as a change in amplitude of the detector position. Interventions that effect respiration will be recorded by an increase or decrease in the amplitude of the detector motion. When used in breath hold, the detector remains in a fixed position with a very narrow gating window. Based on initial experience with the RPM system, it has been found that approximately 1 hour of CPAP use is required to reduce diaphragm motion. Although early results are favorable using this approach, it is not certain that this is the best or most efficient method of use for all patients. The use of CPAP combined with breath hold techniques has not been studied. The objectives of this study are to use the RPM system in normal volunteers to: 1. Study the effects of CPAP on diaphragm motion to allow better optimization for the use of CPAP as a respiratory management technique during free breathing. 2. Determine the feasibility of use of CPAP as a respiratory aid for use in patients treated with breath hold techniques. Determine the effects of CPAP on duration; reproducibility and tolerance of the breath hold technique.

Interventions

BEHAVIORALChest wall movement assessment without CPAP

While subject is breathing normally, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.

BEHAVIORALBreath hold assessment without CPAP

While subject is breathing normally, subject will perform a moderate and a deep inspiratory breath hold. Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.

PROCEDUREChest wall movement assessment with CPAP

While subject is breathing via CPAP machine, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.

PROCEDUREBreath hold assessment with CPAP

While subject is breathing via CPAP machine, subject will perform a moderate and a deep inspiratory breath hold. Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal volunteers without a cancer diagnosis. * No contraindications to the use of CPAP * Facial injury or deformity preventing wearing facial mask * Recurrent vomiting * Chronic cough with phlegm * Previous pneumothorax * Facial lacerations or fractures * Recent tracheal or esophageal anastomosis * Recent GI surgery (last 90 days). * 18-90 years of age * Ability to sign informed consent * Hebrew or English speakers

Exclusion criteria

* Contraindications to CPAP * Facial injury or deformity preventing wearing facial mask * Recurrent vomiting * Chronic cough with phlegm * Previous pneumothorax * Facial lacerations or fractures * Recent tracheal or esophageal anastomosis * Recent GI surgery (last 90 days). * Under age 18 or above age 90 years * Inability to sign informed consent * Members of special populations (mental illness, pregnant women, prisoners, not legally competent). * History of severe active restrictive or obstructive lung disease (as defined as at least one hospitalization over previous two years) * Any medical condition requiring an inpatient hospitalization for more than 72 hours over the previous 2 years, aside from elective surgery.

Design outcomes

Primary

MeasureTime frameDescription
Chest wall motion amplitude2 hoursAmplitude of chest wall motion, measured in centimeters.

Secondary

MeasureTime frameDescription
Duration of breath hold2 hoursLength (in seconds) that are subjects able to hold their breath.
Reproducibility of breath hold depth2 hoursWhen 'breath hold' is performed three consecutive times, ascertain if it performed to the same depth each time. Measured in centimeters.
Respiratory rate2 hoursNumber of breaths per minute.

Countries

Israel

Contacts

Primary ContactHila Gnessin
Hila.Gnessin@sheba.health.gov.il972-3-5307340
Backup ContactEve Keret
Eve.Keret@sheba.health.gov.il972-3-5303207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026